Medical Properties Trust (NYSE:MPW) Price Target Raised to $5.00

Medical Properties Trust (NYSE:MPW) had its price objective increased by Royal Bank of Canada from $4.00 to $5.00 in a research note issued to investors on Monday morning,Benzinga reports. The brokerage currently has a sector perform rating on the real estate investment trust’s stock.

Other research analysts also recently issued reports about the company. Mizuho reduced their target price on Medical Properties Trust from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Thursday, December 5th. Wells Fargo & Company boosted their price target on Medical Properties Trust from $4.00 to $5.00 and gave the stock an “underweight” rating in a research report on Monday. Truist Financial dropped their price target on Medical Properties Trust from $6.00 to $4.00 and set a “hold” rating for the company in a research report on Thursday, December 19th. Finally, StockNews.com upgraded Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Monday, March 3rd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $5.64.

Medical Properties Trust Trading Up 4.6 %

Shares of MPW stock opened at $5.97 on Monday. The company has a debt-to-equity ratio of 1.69, a current ratio of 2.38 and a quick ratio of 2.38. The company has a market cap of $3.58 billion, a price-to-earnings ratio of -1.41, a PEG ratio of 1.01 and a beta of 1.32. The stock has a 50 day simple moving average of $4.72 and a 200-day simple moving average of $4.71. Medical Properties Trust has a 1-year low of $3.51 and a 1-year high of $6.55.

Medical Properties Trust Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 10th. Shareholders of record on Monday, March 10th will be issued a $0.08 dividend. This represents a $0.32 annualized dividend and a yield of 5.36%. The ex-dividend date is Monday, March 10th. Medical Properties Trust’s payout ratio is currently -8.42%.

Insider Buying and Selling at Medical Properties Trust

In other news, CAO James Kevin Hanna sold 11,641 shares of the stock in a transaction on Thursday, December 26th. The stock was sold at an average price of $3.72, for a total transaction of $43,304.52. Following the completion of the transaction, the chief accounting officer now directly owns 366,913 shares in the company, valued at approximately $1,364,916.36. This represents a 3.08 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.53% of the stock is owned by company insiders.

Hedge Funds Weigh In On Medical Properties Trust

Hedge funds have recently modified their holdings of the business. Truvestments Capital LLC purchased a new position in shares of Medical Properties Trust during the 3rd quarter worth $31,000. Allworth Financial LP grew its holdings in shares of Medical Properties Trust by 230.4% during the 4th quarter. Allworth Financial LP now owns 6,082 shares of the real estate investment trust’s stock worth $26,000 after purchasing an additional 4,241 shares during the period. Verus Capital Partners LLC purchased a new position in shares of Medical Properties Trust during the 4th quarter worth $40,000. RS Crum Inc. purchased a new position in shares of Medical Properties Trust during the 4th quarter worth $40,000. Finally, RFG Advisory LLC acquired a new position in Medical Properties Trust during the 4th quarter worth about $40,000. 71.79% of the stock is currently owned by hedge funds and other institutional investors.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.